Viewing Study NCT06601192


Ignite Creation Date: 2025-12-24 @ 3:24 PM
Ignite Modification Date: 2026-01-19 @ 3:21 AM
Study NCT ID: NCT06601192
Status: COMPLETED
Last Update Posted: 2025-07-28
First Post: 2024-08-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults
Sponsor: Enanta Pharmaceuticals, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module